DE69835154D1 - Verfahren zur Bestimmung von Analyten mittels Antigenen, die in Thermoplasten eingebettet sind - Google Patents

Verfahren zur Bestimmung von Analyten mittels Antigenen, die in Thermoplasten eingebettet sind

Info

Publication number
DE69835154D1
DE69835154D1 DE69835154T DE69835154T DE69835154D1 DE 69835154 D1 DE69835154 D1 DE 69835154D1 DE 69835154 T DE69835154 T DE 69835154T DE 69835154 T DE69835154 T DE 69835154T DE 69835154 D1 DE69835154 D1 DE 69835154D1
Authority
DE
Germany
Prior art keywords
analytes
thermoplastics
determination
antigens
embedded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69835154T
Other languages
English (en)
Other versions
DE69835154T2 (de
Inventor
Concepts Llc Embedded
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Embedded Concepts LLC
Original Assignee
Embedded Concepts LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Embedded Concepts LLC filed Critical Embedded Concepts LLC
Publication of DE69835154D1 publication Critical patent/DE69835154D1/de
Application granted granted Critical
Publication of DE69835154T2 publication Critical patent/DE69835154T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815—Carrier is a synthetic polymer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815—Carrier is a synthetic polymer
    • Y10S530/817—Entrapped within the carrier, e.g. gel, hollow fibre
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69835154T 1997-08-12 1998-08-12 Verfahren zur Bestimmung von Analyten mittels Antigenen, die in Thermoplasten eingebettet sind Expired - Fee Related DE69835154T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/909,889 US6177282B1 (en) 1997-08-12 1997-08-12 Antigens embedded in thermoplastic
US909889 1997-08-12
PCT/US1998/016575 WO1999008113A1 (en) 1997-08-12 1998-08-12 Antigens embedded in thermoplastic

Publications (2)

Publication Number Publication Date
DE69835154D1 true DE69835154D1 (de) 2006-08-17
DE69835154T2 DE69835154T2 (de) 2007-06-06

Family

ID=25427986

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69835154T Expired - Fee Related DE69835154T2 (de) 1997-08-12 1998-08-12 Verfahren zur Bestimmung von Analyten mittels Antigenen, die in Thermoplasten eingebettet sind

Country Status (9)

Country Link
US (3) US6177282B1 (de)
EP (2) EP1005652B1 (de)
JP (1) JP2001512832A (de)
AU (1) AU753093B2 (de)
CA (1) CA2300381A1 (de)
DE (1) DE69835154T2 (de)
DK (1) DK1005652T3 (de)
ES (1) ES2268786T3 (de)
WO (1) WO1999008113A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177282B1 (en) * 1997-08-12 2001-01-23 Mcintyre John A. Antigens embedded in thermoplastic
US7018798B2 (en) * 1997-08-12 2006-03-28 Embedded Concepts, Llc Nucleic acid antigens embedded in thermoplastic
US6713309B1 (en) 1999-07-30 2004-03-30 Large Scale Proteomics Corporation Microarrays and their manufacture
US7407668B2 (en) * 2002-01-24 2008-08-05 Boston Scimed, Inc. Medical articles having enzymatic surfaces for localized therapy
JP4758342B2 (ja) * 2003-06-03 2011-08-24 キャンティマー インコーポレイテッド 相変化センサー
WO2005041662A1 (en) * 2003-10-03 2005-05-12 Visionary Biomedical, Inc. Method for treating collagenous tissue
DE102004048685A1 (de) * 2003-10-06 2005-05-25 Research Organization Of Information And Systems Verfahren zum Nachweis von Biopolymeren, Biochips, Verfahren zur Immobilisierung von Antikörpern und Substrate auf denen Antikörper immobilisiert sind
US7192910B2 (en) * 2003-10-28 2007-03-20 Sachem, Inc. Cleaning solutions and etchants and methods for using same
US7709256B2 (en) * 2004-04-28 2010-05-04 Vaxdesign Corp. Disease model incorporation into an artificial immune system (AIS)
US8071373B2 (en) 2004-04-28 2011-12-06 Sanofi Pasteur Vaxdesign Corp. Co-culture lymphoid tissue equivalent (LTE) for an artificial immune system (AIS)
US8030070B2 (en) * 2004-04-28 2011-10-04 Sanofi Pasteur Vaxdesign Corp. Artificial lymphoid tissue equivalent
US7785883B2 (en) * 2004-04-28 2010-08-31 Vax Design Corp. Automatable artificial immune system (AIS)
US8298824B2 (en) 2004-04-28 2012-10-30 Sanofi Pasteur Vaxdesign Corporation Methods of evaluating a test agent in a diseased cell model
US7771999B2 (en) * 2004-04-28 2010-08-10 Vaxdesign Corp. Disease model incorporation into an artificial immune system (AIS)
US7855074B2 (en) * 2004-04-28 2010-12-21 Vaxdesign Corp. Artificial immune system: methods for making and use
US7785806B2 (en) * 2004-04-28 2010-08-31 Vaxdesign Corporation Method for determining the immunogenicity of an antigen
US20070141552A1 (en) * 2004-04-28 2007-06-21 Warren William L Automatable artificial immune system (AIS)
US20060275270A1 (en) * 2004-04-28 2006-12-07 Warren William L In vitro mucosal tissue equivalent
EP1949108B1 (de) 2005-11-18 2013-09-25 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Modifizierte cardiolipin und verwendungszwecken dafür
US8778619B2 (en) 2005-11-18 2014-07-15 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Oxidized cardiolipin and uses to detect cardiolipin antibodies
AU2006331504A1 (en) 2005-12-21 2007-07-05 Vaxdesign Corporation In vitro germinal centers
DE602006019638D1 (de) * 2005-12-21 2011-02-24 Vaxdesign Corp Iin vitro methode um eine potentielle reaktion eines tieres an einen agenten zu bestimmen
US8642307B2 (en) * 2006-05-25 2014-02-04 Nalge Nunc International Corporation Cell culture surface chemistries
AU2007345747A1 (en) * 2006-06-27 2008-08-07 Vaxdesign Corporation Models for vaccine assessment
US8171270B2 (en) * 2006-12-29 2012-05-01 Intel Corporation Asynchronous control transfer
WO2009048661A1 (en) 2007-07-16 2009-04-16 Vaxdesign Corporation Artificial tissue constructs comprising alveolar cells and methods for using the same
BRPI0906544A2 (pt) * 2008-04-05 2019-01-02 Single Cell Tech Inc método de obtenção de informação a partir de células isoladas de interesse.
KR102242183B1 (ko) * 2013-06-18 2021-04-20 테르모조메 게엠베하 장기 순환 자극-민감성 나노운반체 시스템에 의한 국소부위 치료를 위한 입체 특이적 지질
JP2015083969A (ja) * 2013-09-19 2015-04-30 株式会社リコー 検査装置、転写材、検査装置の製造方法、及び検査方法
US9757330B2 (en) 2013-10-18 2017-09-12 Industrial Technology Research Institute Recipe for in-situ gel, and implant, drug delivery system formed thereby
CN111295094A (zh) 2017-10-09 2020-06-16 泰尔茂比司特生物技术有限公司 冻干容器及使用冻干容器的方法
US10191036B1 (en) 2018-03-22 2019-01-29 NUB4U, Inc. System for detecting and removing biological analytes in fluids
CA3130700A1 (en) 2019-03-14 2020-09-17 Terumo Bct Biotechnologies, Llc Lyophilization container fill fixture, system and method of use
CN117288948B (zh) * 2023-06-19 2024-06-04 无锡嘉润诊断技术有限公司 抗凝血酶原抗体检测试剂盒

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4118349A (en) 1971-05-12 1978-10-03 Behringwerke Aktiengesellschaft Process for the manufacture of polystyrene latex compounds
US3766013A (en) * 1971-08-24 1973-10-16 American Cyanamid Co Preparation of water-insoluble carrier bound enzymes
US3767790A (en) * 1972-02-11 1973-10-23 Nat Patent Dev Corp Microorganisms
IT1008202B (it) * 1974-07-31 1976-11-10 Lostia Onofrio Fibre inglobanti anticorpi antige ni antisieri procedimento per la loro preparazione e loro impieghi
US4195127A (en) * 1975-06-10 1980-03-25 W. R. Grace & Co. Process for immobilizing proteins
US4360358A (en) 1980-03-07 1982-11-23 Yash Sharma Immunoassay with solid phase having coating containing blood platelet substitute
US4407957A (en) * 1981-03-13 1983-10-04 Damon Corporation Reversible microencapsulation of a core material
US4390343A (en) 1981-07-06 1983-06-28 Miles Laboratories, Inc. Multilayer analytical element having an impermeable radiation diffusing and blocking layer
US4459362A (en) 1982-02-02 1984-07-10 Hana Biologics, Inc. Immunoassay of phospholipid, such as phosphatidyl choline, in fluids such as amniotic
US4738724A (en) * 1983-11-04 1988-04-19 Warner-Lambert Company Method for forming pharmaceutical capsules from starch compositions
US4609707A (en) * 1983-11-10 1986-09-02 Genetic Systems Corporation Synthesis of polymers containing integral antibodies
US4752638A (en) * 1983-11-10 1988-06-21 Genetic Systems Corporation Synthesis and use of polymers containing integral binding-pair members
US4673438A (en) * 1984-02-13 1987-06-16 Warner-Lambert Company Polymer composition for injection molding
IL72924A (en) * 1984-09-12 1988-07-31 I D L International Diagnostic Preparations for use in solid phase immunoassays comprising monoclonal antibodies covalently embedded in their immobilized hybridoma cells
US4656035A (en) * 1984-12-21 1987-04-07 University Of Tennessee Research Corporation Method of separating blood platelets
CA1272127A (en) * 1985-04-04 1990-07-31 Hybritech Incorporated Solid phase system for use in ligand-receptor assays
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US5785989A (en) * 1985-05-01 1998-07-28 University Utah Research Foundation Compositions and methods of manufacturing of oral dissolvable medicaments
US5200270A (en) * 1986-02-25 1993-04-06 Toyo Soda Manufacturing Co., Ltd. Carrier for a biologically active component for immunoassay or enzymatic reaction
DE3637421C1 (de) * 1986-11-03 1987-10-29 Nerbe Plus Ges Fuer Medizinisc Reaktionsgefaess fuer die Blutgerinnungsreaktion
US5723588A (en) * 1986-11-04 1998-03-03 Protein Polymer Technologies, Inc. Protein-enriched thermoplastics
US4822747A (en) * 1986-12-09 1989-04-18 Miles Inc. Polyacrylamide gel particles having hapten moieties bound thereto as immunoassay reagent
WO1988009149A1 (en) * 1987-05-29 1988-12-01 The Royal North Shore Hospital And Area Health Ser Medical testing device
US4827944A (en) 1987-07-22 1989-05-09 Becton, Dickinson And Company Body fluid sample collection tube composite
US5236703A (en) * 1987-08-20 1993-08-17 Virex Inc. Polymeric substrates containing povidone-iodine as a control release biologically active agent
US5258503A (en) * 1987-09-08 1993-11-02 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Autoantibody adsorbent and apparatus for removing autoantibodies using the same
US5277915A (en) * 1987-10-30 1994-01-11 Fmc Corporation Gel-in-matrix containing a fractured hydrogel
US5234841A (en) * 1987-12-18 1993-08-10 Eastman Kodak Company Methods of preparing a polymeric latex composition and water-insoluble biological reagent
US5013669A (en) * 1988-06-01 1991-05-07 Smithkline Diagnostics, Inc. Mass producible biologically active solid phase devices
FR2635019B1 (fr) * 1988-08-02 1992-06-12 Centre Nat Rech Scient Materiau capable de fixer les substances biologiques, et ses applications notamment comme support de chromatographie d'affinite
SE8900130L (sv) * 1989-01-16 1990-07-17 Klaus Mosbach Konceptet att med hjaelp av molekylavtrycksmetoden framstaella konstgjorda antikroppar genom imprinting av t ex antigener samt att framstaella konstgjorda entzymer genom imprintning med transition state analoger
WO1990010227A1 (en) 1989-02-27 1990-09-07 Biostar Medical Products, Inc. Method and diagnostic test kit for detection of anti-cardiolipin
US5428008A (en) * 1989-04-14 1995-06-27 Prp, Inc. Therapeutic composition of micellar structures capable of promoting hemotasis
US5318899A (en) * 1989-06-16 1994-06-07 Cor Therapeutics, Inc. Platelet aggregation inhibitors
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
ATE142789T1 (de) * 1989-10-19 1996-09-15 Yamasa Shoyu Kk Träger zur bindung von antiphospholipid- antikörpern, diese antikörper verwendender immunotest und kit dafür
US5580770A (en) * 1989-11-02 1996-12-03 Alliedsignal Inc. Support containing particulate adsorbent and microorganisms for removal of pollutants
WO1991010138A1 (en) 1989-12-27 1991-07-11 Baxter Diagnostics Inc. Method to immobilize cardiolipin, phosphatidyl choline and cholesterol to solid phase and immunoassay
IL93134A (en) * 1990-01-23 1997-11-20 Yissum Res Dev Co Doped sol-gel glasses for obtaining chemical interactions
CA2058769C (en) * 1990-04-06 1999-03-02 Steven Anthony Krilis Methods for determining phospholipids and antibodies thereof
DE4027728A1 (de) * 1990-08-31 1992-03-05 Bayer Ag Immobilisierung von organischen makromolekuelen oder biopolymeren in einer polymermembran
HU214736B (hu) * 1991-05-17 1998-08-28 Fuisz Technologies Ltd. Eljárás enzimhordozó mátrixot tartalmazó enzimtermékek előállítására
AU2310992A (en) * 1991-07-12 1993-02-11 Toxi Lab, Inc. Method and apparatus for improved solid phase extraction
AU2605592A (en) * 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US5424219A (en) * 1991-10-25 1995-06-13 Cytech Biomedical, Inc. Method of performing assays for biomolecules and solid supports for use in such methods
SE9103234D0 (sv) * 1991-11-04 1991-11-04 Bjoern Ekberg Foerfarande foer separering av enantiomerer av aryloxipropanolaminderivat och kiralt fastfaskromatografimaterial foer anvaendning vid foerfarandet
US5413924A (en) * 1992-02-13 1995-05-09 Kosak; Kenneth M. Preparation of wax beads containing a reagent for release by heating
US5372719A (en) * 1992-03-30 1994-12-13 Perseptive Biosystems, Inc. Molecular imaging
US5414075A (en) 1992-11-06 1995-05-09 Bsi Corporation Restrained multifunctional reagent for surface modification
US6022748A (en) * 1997-08-29 2000-02-08 Sandia Corporation - New Mexico Regents Of The University Of California Sol-gel matrices for direct colorimetric detection of analytes
WO1994017106A1 (en) * 1993-01-19 1994-08-04 Pharmacia P-L Biochemicals, Inc. Storage and delivery of purified protein reagents with carrier wax
US5599660A (en) * 1993-01-19 1997-02-04 Pharmacia Biotech Inc. Method and preparation for sequential delivery of wax-embedded, inactivated biological and chemical reagents
ATE165917T1 (de) * 1993-02-03 1998-05-15 Histaggen Inc Automatisiertes histo-zytochemisches gerät und einkapselungssystem zum behandeln von biologischem material
US5472852A (en) * 1993-09-15 1995-12-05 Oklahoma Medical Research Foundation Assay for detection of selective Protein C inhibition by patients
US6127154A (en) * 1994-02-10 2000-10-03 Mosbach; Klaus Methods for direct synthesis of compounds having complementary structure to a desired molecular entity and use thereof
US5994110A (en) * 1995-02-10 1999-11-30 Mosbach; Klaus Methods for direct synthesis of compounds having complementary structure to a desired molecular entity and use thereof
US5739244A (en) * 1994-03-23 1998-04-14 Fisk; Donald Polymer composition containing prime starch
US5582907A (en) * 1994-07-28 1996-12-10 Pall Corporation Melt-blown fibrous web
AT401653B (de) * 1994-10-05 1996-11-25 Avl Verbrennungskraft Messtech Verfahren zur immobilisierung biologischer komponenten in einer polymermatrix sowie biosensoren unter verwendung derartiger immobilisate
AU5859796A (en) * 1995-05-26 1996-12-11 Igen, Inc. Molecularly imprinted beaded polymers and stabilized suspens ion polymerization of the same in perfluorocarbon liquids
US6027721A (en) * 1996-05-20 2000-02-22 Cytotherapeutics, Inc. Device and method for encapsulated gene therapy
US6054142A (en) * 1996-08-01 2000-04-25 Cyto Therapeutics, Inc. Biocompatible devices with foam scaffolds
US7018798B2 (en) * 1997-08-12 2006-03-28 Embedded Concepts, Llc Nucleic acid antigens embedded in thermoplastic
US6177282B1 (en) * 1997-08-12 2001-01-23 Mcintyre John A. Antigens embedded in thermoplastic

Also Published As

Publication number Publication date
CA2300381A1 (en) 1999-02-18
AU8902298A (en) 1999-03-01
EP1005652A4 (de) 2002-06-26
EP1005652A1 (de) 2000-06-07
DK1005652T3 (da) 2006-10-30
US6872576B1 (en) 2005-03-29
WO1999008113A1 (en) 1999-02-18
ES2268786T3 (es) 2007-03-16
AU753093B2 (en) 2002-10-10
US6177282B1 (en) 2001-01-23
US20050042774A1 (en) 2005-02-24
EP1005652B1 (de) 2006-07-05
EP1715342A1 (de) 2006-10-25
DE69835154T2 (de) 2007-06-06
JP2001512832A (ja) 2001-08-28

Similar Documents

Publication Publication Date Title
DE69835154D1 (de) Verfahren zur Bestimmung von Analyten mittels Antigenen, die in Thermoplasten eingebettet sind
ATE318146T1 (de) Verfahren zur aufkonzentrierung von antikörperlösungen
DE69824845D1 (de) Verfahren zur aufkonzentration von kohlenwasserstoffen
DE69836493D1 (de) Vorrichtung zur bestimmung von mehreren analyten
DE69806802D1 (de) Verfahren zur unterscheidung von erythroblasten
DE69926418D1 (de) Vorrichtung zur Bestimmung von Hämodialyseparametern
DE59905443D1 (de) Verfahren zur herstellung von aldehyden
DE69518550D1 (de) Verfahren zur bereitung von kohlenwasserstoffe
DE69719179D1 (de) Vorrichtung zur bestimmung der narkose-tiefe
DE59708888D1 (de) Verfahren zur bestimmung von grössen, die das fahrverhalten eines fahrzeugs beschreiben
DE59707217D1 (de) Verfahren zur bestimmung von grössen, die das fahrverhalten eines fahrzeugs beschreiben
DE69830556D1 (de) Verfahren zur Bestimmung von glykosylierten Proteinen
DE59806044D1 (de) Verfahren zur ermittlung von segmentzeiten
ATE264285T1 (de) Verfahren zur herstellung von haloginierten kohlenwasserstoffen
DE69810301D1 (de) Verfahren zur herstellung von halogenierten kohlenwasserstoffen
DE69804331D1 (de) Verfahren zur herstellung von flüssigen kohlenwasserstoffen
DE69805933D1 (de) Verfahren zur herstellung von ironen
DE69903135D1 (de) Verfahren zur herstellung von hochfester aluminiumfolie
DE69109868D1 (de) Verfahren zur bestimmung von dns-sequenzen.
DE69610421D1 (de) Verfahren zur herstellung von alpha,beta-ungesättigten nitrilen
ATA96398A (de) Verfahren zur bestimmung von antigenen
DE69319752D1 (de) Verfahren zur identifizierung von analyten
DE69819191D1 (de) Verfahren zur herstellung von pentafluorethan
DE69534877D1 (de) Verfahren zur bestimmung von bilirubin
DE69818426D1 (de) Verfahren zur herstellung von polyacrylamiddispersionen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee